We previously demonstrated that treatment of human podocytes with the sera from patients with DKD leads to decreased ABCA1 expression and cholesterol accumulation due to impaired cholesterol efflux and podocyte injury [50,51]. Here, ABCA1 is linked to diabetic kidney disease.